What Sofipaca does

Sofipaca is a regional private capital investment firm (société de capital investissement) headquartered in Aix-en-Provence, France, with a secondary office in Saint-Laurent-du-Var (Nice). Founded in 1900 as the equity investment vehicle of Crédit Agricole in the Provence-Alpes-Côte d'Azur region, the company is wholly owned by two regional cooperative banks — Crédit Agricole Alpes Provence and Crédit Agricole Provence Côte d'Azur — and operates within the broader "Capital Investissement by Groupe CA" network of 12+ affiliated entities. Sofipaca invests its own funds as a minority shareholder with a long-term horizon, targeting growing and profitable SMEs and mid-cap companies (ETIs) across the Région Sud of France, excluding real estate.

The firm offers two core financial products: Capital Investissement (minority equity) with tickets of 1-7M€ from own funds and up to 30M€ with co-investors, and Dette Privée (private debt) offering 2-5M€ non-dilutive bonds or mezzanine financing repayable in fine over 7-8 years. Equity investments are structured as either Capital Développement (growth acceleration, organic and external) or Capital Transmission (shareholder liquidity while preserving management control). Sofipaca maintains approximately 40 active portfolio companies across diversified sectors including hospitality, healthcare, logistics, industrial equipment, renewable energy, IT services, agriculture, and professional services.

The business model is relationship-driven and regionally concentrated: deal sourcing relies on direct outreach, regional presence, referrals through the Crédit Agricole banking network, and memberships in France Invest and Ambition Capital. The team comprises approximately 6 professionals led by Directeur Général Alexandre Flageul (joined 2016, ex-Arthur Andersen, SG Asset Management, Amundi). Sofipaca reinvests all profits into new territorial projects rather than distributing dividends to its shareholder banks. As a subsidiary of Crédit Agricole Group, the firm benefits from permanent capital backing, co-investment syndication capabilities, and embedded credibility with regional SMEs — factors that translate into high deal throughput relative to team size.

Name

Sofipaca

Legal name

SOFIPACA

Website

https://sofipaca.fr

Company type

Private

Founded year

1900

Operating status

Operating

Headcount range

1–10 employees

Short description

Sofipaca is a regional private equity and private debt firm in Aix-en-Provence, France, owned by Crédit Agricole regional banks, providing minority equity (1-7M€) and non-dilutive financing (2-5M€) to growing SMEs and mid-caps in Southern France.

Ownership category

akta.pro rank

Product category

Private Equity / Regional Capital Investment

NAICS

All Other Financial Investment Activities (52399)

SIC

Investors, Nec (6799)

akta.pro primary industry

Micro-PE / Lower Middle Market ETA Funds (FSANALAG)

Keywords

• Private equity investment
• Minority equity capital
• Growth capital financing
• Private debt financing
• Business succession capital

Headquarters

HQ city

Aix-en-provence

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Capital Investment Returns: Sofipaca generates returns through equity investments in portfolio companies, realizing gains upon exit or dividend distributions. As an investor on own funds with a long-term vision, returns are realized through capital appreciation and periodic distributions to shareholders (Crédit Agricole regional banks).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Sofipaca is a regional capital investment company (Société de Capital Risque) that provides minority equity investments and private debt financing to growing SMEs and mid-caps (ETIs) in the Région Sud of France. The firm invests 1 to 7 million euros per operation from its own funds (up to 30 million euros with co-investors) as an active and engaged long-term minority shareholder. Its offering is structured around two core financial products—Capital Investissement (equity) and Dette Privée (private debt)—delivered through two approaches: Capital Développement for growth acceleration and Capital Transmission for shareholder liquidity and business succession.

Product overview

Sofipaca is a regional capital investment company (SCR) affiliated with Crédit Agricole, operating as a minority shareholder with a long-term vision. The company offers two main financial products: Capital Investissement (private equity) providing 1-7 million euros per operation for growth and transmission, and Dette Privée (private debt) offering 2-5 million euro non-dilutive financing tools. These core products are complemented by investment approaches categorized as Capital Transmission (ownership transfer with executive control) and Capital Développement (growth acceleration through organic development and acquisitions).

Differentiator

Problem solved

Functional benefit

Products and services

• Capital Investissement Minority equity investment service providing long-term capital to SMEs and mid-caps (ETIs) in the Région Sud of France to accelerate internal development and external growth through acquisitions. Investment tickets range from 1 to 7 million euros from own funds, up to 30 million euros with co-investors. Offered as a long-term, engaged minority shareholding position with reinvestment of profits into new territory projects.
• Dette Privée Non-dilutive private debt financing service for growing SMEs and ETIs in the Région Sud, offering flexible investment tools including simple bonds, mezzanine debt, with or without simultaneous equity operations. Financing tickets range from 2 to 5 million euros, repayable in fine over 7-8 years. Designed as a complement to or alternative to equity investment.
• Capital Transmission Equity investment approach enabling shareholder liquidity and business succession/transmission while preserving capital control by executives. Used to facilitate ownership transfer, generational handover, and shareholder exits in regional SMEs and ETIs. Examples include investments in Groupe ODICE, Ebhys, Château Virant, Ansemble, Caractère & Sira, Hermès Plage, X-RAY PHOCEA, Marcel & Fils, Vectorys, Berto, Apside, Vivalto Santé.
• Capital Développement Equity investment approach enabling companies to accelerate internal development and/or realize external growth through acquisitions. Used to fund organic growth initiatives and bolt-on or transformational acquisitions in regional SMEs and ETIs. Examples include investments in Summer Hôtels, Kenatra Hospitality, Huttopia, Sofilec, Domaines de Fontenille, Soleil du sud, Pellenc ST, Compagnie Fruitière, Vitalis.

Named customers21 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered minor.

• France InvestminorOthersNational private equity association member, signatory of France Invest gender parity charter.
• Ambition CapitalminorOthersAssociation grouping professional investors in Southern France region.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Unexo: Direct sister entity within Crédit Agricole Group's Capital Investissement network, providing similar minority equity and transmission capital to SMEs in Pays de la Loire. Closest comparable given shared ownership, mandate, and operating model.
• Idia Capital Investissement: Crédit Agricole Group's national SME/ETI private equity arm. Provides minority equity and quasi-equity to French SMEs/ETIs, closely matching Sofipaca's mandate and ticket size with broader geographic reach.
• Socadif: Regional Crédit Agricole PE firm serving SMEs in the Centre-France region with long-term patient capital. Same template as Sofipaca — affiliated regional PE subsidiary with own-funds and co-investment model.
• Carvest: Crédit Agricole regional PE vehicle (Île-de-France). Direct sister entity with similar minority-equity, long-term capital approach for SMEs/ETIs.
• Sodicar (Crédit Agricole Normandie Investissement): Normandy-based Crédit Agricole regional PE firm investing in regional SMEs/ETIs through transmission and development capital. Same structural model as Sofipaca.
• IRDI Soridec: Independent regional PE firm in the South of France (Toulouse/Occitanie), investing minority equity and mezzanine in SMEs/ETIs. Direct competitor for the same regional mid-market with similar patient-capital philosophy.

Regional players

• Midi Capital: Toulouse-based regional PE firm targeting SMEs in Occitanie and South-West France. Similar deal size (€1-10M) and minority equity strategy, serving adjacent (non-overlapping) Southern French territory.
• Galia Gestion: Bordeaux-based regional PE firm investing in SMEs/ETIs in South-West France. Similar minority-equity, long-term capital approach in adjacent regional territory.

Broad incumbents

• Siparex: Larger multi-regional French PE group (Lyon-headquartered) operating across France with regional offices and broader fund offerings. Competes for the same French SME/ETI transmission deals at slightly larger ticket sizes.
• Bpifrance Investissement: French national development bank and PE investor. Regular co-investment partner with Sofipaca (e.g., Summer Hôtels, ODICE LBO); competes for larger mid-market deals with state-backed development mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sofipaca
• Xx.com/ca_sofipaca

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sofipaca